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used histocytometry to precisely
visualize iNKT cell subsets in tissues and
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Three subsets of invariant natural killer T (iNKT) cells
have been identified, NKT1, NKT2, and NKT17, which
produce distinct cytokines when stimulated, but little
is known about their localization. Here, we have
defined the anatomic localization and systemic dis-
tribution of these subsets and measured their cyto-
kine production. Thymic NKT2 cells that produced
interleukin-4 (IL-4) at steady state were located in
the medulla and conditioned medullary thymocytes.
NKT2 cells were abundant in the mesenteric lymph
node (LN) of BALB/c mice and produced IL-4 in the
T cell zone that conditioned other lymphocytes.
Intravenous injection of a-galactosylceramide acti-
vated NKT1 cells with vascular access, but not LN
or thymic NKT cells, resulting in systemic inter-
feron-g and IL-4 production, while oral a-galactosyl-
ceramide activated NKT2 cells in the mesenteric
LN, resulting in local IL-4 release. These findings indi-
cate that the localization of iNKT cells governs their
cytokine response both at steady state and upon
activation.
INTRODUCTION
Invariant natural killer T (iNKT) cells are a specialized subset
of T cells that recognize CD1d molecules presenting lipid an-
tigens (Bendelac et al., 2007). When stimulated with the
agonistic lipid a-galactosylceramide (aGalCer), they rapidly
secrete high amounts of several cytokines, and there is
growing interest in exploiting aGalCer as an immunological
adjuvant (Carren˜o et al., 2014; Singh et al., 2014; Venkatasw-
amy et al., 2014). iNKT cells also secrete cytokines at steady
state and early after infection to influence the development
and activation of surrounding immune cells (Engel and Kro-
nenberg, 2014; Lee et al., 2013). Despite being essentially
monospecific, iNKT cells nonetheless display substantial func-
tional heterogeneity, with subsets producing different cyto-
kines having distinct tissue localization preferences (Coquet
et al., 2008; Doisne et al., 2009; Doisne et al., 2011; Michel
et al., 2007; Terashima et al., 2008; Watarai et al., 2012).566 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.Recently, we showed that the three major functionally distinct
subsets of iNKT cells that exist in mice (NKT1, NKT2, and
NKT17 cells) express distinct transcription factor profiles:
T-bet, GATA-3, or RORgt (with distinct levels of promyelocytic
leukemia zinc finger [PLZF]) and that this generally correlates
with their cytokine response upon activation (interferon-g
[IFN-g], interleukin-4 [IL-4], or IL-17, respectively) (Lee et al.,
2013). However, little is known about where these subsets
of iNKT cells are localized during steady state and upon acti-
vation with aGalCer, and identifying these cells by current
methods can be challenging.
iNKT cells can be recognized by staining with CD1d tetramers
and by intracellular staining for the lineage specific transcription
factor PLZF (Kovalovsky et al., 2008; Savage et al., 2008). These
two markers, however, are not readily applicable to immunoflu-
orescence imaging, as CD1d tetramer binding requires live cells
for optimal sensitivity and PLZF is also expressed in subsets of
gd T cells, myeloid cells, and stem cells. For these reasons, con-
ventional methods using fresh frozen or paraformaldehyde-fixed
tissues to stain for iNKT cells raises issues of sensitivity and
specificity. Several reports have tried to visualize iNKT cells us-
ing immunofluorescence. Bendelac and colleagues used CD1d
tetramers to directly stain frozen tissue sections of Va14 trans-
genic (Va14Tg) mice and showed that iNKT cells are mainly local-
ized in the extravascular area or T cell zone of spleen and lymph
node (LN) (Thomas et al., 2011). This technique, however, was
not sensitive enough to detect endogenous iNKT cells in wild-
type (WT) mice and might have preferentially visualized NKT2
cells expressing high numbers of surface T cell receptors
(TCRs), which are abundant in Va14Tg mice. Batista and col-
leagues used TCRb and NK1.1 instead of CD1d tetramers to
detect splenic iNKT cells and showed that most are in the mar-
ginal zone or red pulp of the spleen (Barral et al., 2012). However,
splenic TCRb+NK1.1+ T cells represent only NKT1 cells, and not
NKT2 or NKT17 cells, and some conventional memory T cells
also express NK1.1. In other studies, Va14Tg mice were used
as a source of donor cells and congenic markers were used after
adoptive transfer for immunofluorescence or intravital imaging
(Barral et al., 2010; Chang et al., 2012). However, adoptive trans-
fer might not recapitulate the natural distribution of iNKT popula-
tions, and in some of these experiments, iNKT cells were isolated
using TCRb and CD1d tetramer binding, which could impact the
activation state of the donor cells. Most recently, Leadbetter and
colleagues made thick tissue sections using a vibrating micro-
tome and directly stained sections using CD1d tetramer, which
showed that iNKT cells are dispersed throughout the splenic pa-
renchyma (King et al., 2013). This study successfully visualized
endogenous iNKT cells using CD1d tetramer, but did not sepa-
rate subsets or validate the sensitivity of staining method. Previ-
ous studies have not directly visualized thymic iNKT cells, and
studies that addressed the localization of iNKT cells in spleen
or LN did not provide data on distribution of iNKT subsets.
Here we report an ex vivo technique to visualize endogenous
iNKT cells in thymus, spleen, and LN using CD1d tetramers
and various transcription factors. We employed a histocytomet-
ric algorithm to analyze the data and validate sensitivity. We
found that iNKT subsets are not symmetrically distributed
throughout tissues: thymic NKT2 cells were mainly located in
the medullary area and splenic NKT1 cells preferentially resided
in red pulp, whereas splenic NKT2 cells were abundant in the
T cell zone. We also found that each subset had unique periph-
eral distribution, with some inter-strain variation. Notably, the
mesenteric LNs (mLNs) of BALB/c mice were substantially en-
riched for NKT2 cells.
We show that the distribution of iNKT subsets affected the
cytokine milieu in lymphoid tissues. At steady state, NKT2 cells
in the thymic medulla and T cell zone of the mLN conditioned
lymphocytes to express pSTAT6, consistent with production of
IL-4 by the NKT2 subset. Intravenous (i.v.) injection of aGalCer
rapidly activated NKT1 cells in the splenic red pulp and liver,
which induced systemic IFN-g and IL-4 responses, but not
iNKT cells in LN, thymus, or other tissues. On the other hand,
oral administration of aGalCer activated NKT2 cells in mLN,
which induced a local IL-4 response. As most iNKT cells do
not circulate (Lynch et al., 2015; Thomas et al., 2011), these re-
sults show how the steady-state localization of iNKT cells deter-
mines their systemic or local cytokine responses at steady state
and upon activation, providing conceptual challenges to the
design of therapeutic protocols in humans.
RESULTS
iNKTCell SubsetsCanBeLocalizedwithCD1dTetramer
Immunofluorescence and Histocytometry
We developed a CD1d tetramer immunofluorescence technique
as illustrated in Figure S1A and described in the Experimental
Procedures. We used green fluorescence protein (GFP) reporter
mice for the transcription factor T-bet (Tbx21gfp) or stained for
intracellular RORgt together with CD1d tetramers to identify
NKT1 and NKT17 cells, respectively. RORgt was also highly ex-
pressed on cortical double-positive (DP) thymocytes, which
demarcated the cortex (He et al., 1998) (Figure 1A). In this stain-
ing, NKT2 cells were defined as positive for CD1d tetramer but
negative for both Tbx21gfp and RORgt and, in a separate stain-
ing, we confirmed these cells were all positive for PLZF (data
not shown). We used Cd1d/ mice as a specificity control, in
which we detected minimal background staining (Figure 1B,
lower panel). To address whether this method detects all iNKT
subsets efficiently, we employed a previously described histocy-
tometric algorithm, by which quantitative data from immunofluo-
rescence images are converted into two-dimensional dot plots
(Gerner et al., 2012) (Figure S1B). Figure 1B shows a side-by-
side comparison of the thymic phenotype of iNKT cells by flow
cytometry and histocytometry, which separately evaluatedImeach thymic lobe from a single mouse. When we compared
the frequency of total iNKT cells (Figure 1C) and the fraction in
each subset (Figure S1C) between flow cytometry and histocy-
tometry, no significant differences were observed. These results
demonstrate the utility of this method to visualize distinct sub-
sets of iNKT cells, with a sensitivity and specificity comparable
to flow cytometry.
Medullary Distribution of NKT2 Cells Determines
Localized pSTAT6 Expression
Using the histocytometric algorithm, we tracked the localization
of iNKT subsets and quantified them throughout the thymic cor-
tex and medulla (Figure 2A). We found medullary frequencies of
iNKT cells averaged 2.7% in C57BL/6 (B6) mice and 5.6% in
BALB/c mice, whereas in the cortex, they were 0.27% and
0.32% respectively (Figure S2D). Although the medullary fre-
quency of iNKT cells was about 10 times higher than that of cor-
tex, the thymic cortex occupies, on average, approximately 80%
of the cut section (Irla et al., 2013) and its cellularity is 1.7-fold
higher than that of the medulla (data not shown). Correcting for
this, we estimate that on average 30% of all iNKT cells were in
the thymic cortex regardless of subset or mouse strain (Fig-
ure 2B), in contrast to most mature cell populations that primarily
reside in the medulla. To directly compare this localization
pattern to that of another mature cell lineage in thymus, we
analyzed the localization of thymic regulatory T (Treg) cells using
Foxp3gfp mice (Figure S2A). We found that only 1.5% of Treg
cells resided in the thymic cortex as shown previously (Fontenot
et al., 2005) (Figure 2B). This difference suggests that the cortical
localization of iNKT cells is not due to a passive overflow of med-
ullary lymphocytes, but is actively regulated process.
To track the localization of IL-4 producing cells among total
NKT2 cells, we immunostained human CD2 (huCD2) in Tbx21gfp
mice crossed to KN2+/– mice that express huCD2 on the surface
of cells secreting IL-4 (FiguresS2Band2C).Weobserved that the
majority of huCD2+ NKT2 cells in both B6 and BALB/c mice were
localized in the medulla. However, in BALB/c mice, IL-4 produc-
ing NKT2 cells represented 2.3% of medullary thymocytes (Fig-
ure 2B, right panel), which was 7.4-fold higher than in B6 mice.
This might explain why NKT2 cells condition CD8 single positive
(SP) thymocytes to express Eomesodermin (Eomes) in BALB/c,
but not B6 mice (Lee et al., 2013). We performed flow cytometry
with antibodies to the phosphorylated form of the transcription
factor STAT6 (pSTAT6) to see the range of influence that IL-4
had on thymocytes (Figures 2C and 2D). pSTAT6 was expressed
in medullary SP thymocytes in BALB/c mice, and this was asso-
ciated with Eomes upregulation. Cortical DP thymocytes were
competent for pSTAT6 expression upon in vitro IL-4 stimulation,
but negative for pSTAT6 in vivo at steady state indicating that IL-4
exerts its effectsprimarily onmedullary thymocytesdue to the se-
lective localization of NKT2 cells to the medulla.
iNKT Subsets Have Unique Peripheral Distribution, with
Some Interstrain Variation
We further identified the tissue distribution of iNKT subsets in
three different inbred strains of mice using flow cytometry (Fig-
ure 3A). We analyzed the frequency of iNKT cells among total
CD45+cells or frequencies of each subset among total iNKTcells.
An i.v. labeling method was used to quantify iNKT cells residingmunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc. 567
Figure 1. iNKT Cells Localized with CD1d Tetramer Immunofluorescence and Histocytometry
(A) Thymi of B6 and BALB/c Tbx21gfp mice and BALB/c Cd1d/ mouse were stained with CD1d tetramer (red), RORgt (blue), and DAPI (gray) to visualize and
distinguish NKT1, NKT2, and NKT17 cells. Arrows indicate NKT1 (green), NKT2 (red), and NKT17 (blue) cells. M, medulla; C, cortex.
(B) Each thymic lobe from BALB/c Tbx21gfp mouse was subjected to histocytometric analysis after immunofluorescence staining or to flow cytometry analysis.
Representative plots are shown among four different experiments.
(C) Frequencies of total iNKT cells in thymus obtained from histocytometry and flow cytometry were compared in seven different sections obtained from four
different B6 or BALB/c Tbx21gfp mice. NS, not significant (paired t test). See also Figure S1.within lung parenchyma (i.v.) or inside the blood vasculature
(i.v.+) (Figure S3). The liver contained the highest frequency of
iNKT cells in all three strains, followed by the lung (i.v.), spleen,
and thymus. iNKT cells were generally less abundant in LN and
intestinal tissues. Subset analysis revealed that NKT1 cells
were particularly enriched in liver and NKT17 cells in lung (i.v.)
and LNs (Figure 3B and Figure S3), consistent with previous pub-
lications (Michel et al., 2007; Webster et al., 2014). mLNs were
notably distinct, showing a high frequency of iNKT cells in
BALB/c mice and relative abundance of NKT2 cells in all strains
(Figures 3Aand3B). Among totalCD45+ lymphocytes,NKT1cells
were overrepresented in the liver, NKT17 cells in the lung (i.v.),
andNKT2 cells in BALB/cmLN (Figure 3C). Collectively, these re-
sults show that iNKT subsets are uniquely distributed in periph-
eral lymphoid and non-lymphoid organs with some inter-strain
variation, especially in the mLN.
NKT2 Cells in BALB/c mLN Produce IL-4 and Condition
Lymphocytes at Steady State
Because mLNs were unique in their iNKT subset distribution, we
further analyzed their properties. We previously showed that the568 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.transcription factor NUR77 is a marker of antigen receptor sig-
naling and that in Nur77gfp reporter mice, GFP is upregulated
in iNKT cells after synthetic lipid challenge (Lee et al., 2013;
Moran et al., 2011). Interestingly, NKT2 cells in themLNs showed
higher GFP expression in BALB/c Nur77gfp mice (Figure S4A),
and BALB/c mice contained a 10-fold higher frequency of
NKT2 cells than B6 or NODmice (Figures 4A and 4B). To observe
the distribution of iNKT cells within the LN, we performed CD1d
tetramer histocytometry. We discriminated the B cell area (or fol-
licle), T cell area (or paracortex), and medulla. In both inguinal
and mesenteric LNs, BALB/c iNKT cells were more enriched in
the T cell zone compared to B6 (Figures 4C and 4D and Figures
S4B and 4C). Consistent with a previous report (Gray et al.,
2012), we found that some NKT17 cells are located in the sub-
capsular area (Figure S4B). In the mLN, BALB/c NKT2 cells
were particularly enriched in the T cell zone, (Figures 4C and
4D) and analysis of KN2mice showed an 8-fold higher frequency
of IL-4 producing iNKT cells in BALB/c mice compared to those
of B6 mice (Figure 4E). Consistent with this, a proportion of
T cells in the mLN of BALB/c mice constitutively expressed
pSTAT6 (Figures 4F and 4G), unlike T cells in spleen, inguinal
Figure 2. Medullary Distribution of NKT2 Cells Determines Localized pSTAT6 Expression
(A) Thymi of BALB/c Tbx21gfp mice were stained with indicatedmarkers and analyzed localization of each subset using histocytometric algorithm. Representative
figures from at least five independent experiments are shown. M, medulla; C, cortex.
(B) Cortical frequencies of thymic iNKT cells in B6 and BALB/c Tbx21gfp mice were analyzed (left) and frequencies of human CD2 (huCD2)+ NKT2 cells were
calculated in thymic medulla (right). Pooled data from seven to nine different sections using four different mice are shown. *p = 0.032, **p < 0.016, ***p < 0.0005
(unpaired t test). Each dot represents an individual section and horizontal bars indicate mean values.
(C) Histograms of pSTAT6 expression of double-positive (DP) andCD8 single-positive (SP) thymocytes are shown from indicatedmouse strains with or without IL-
4 (10ng/ml) treatment for 30 min ex vivo. Representative results of five independent experiments are shown. All histograms have the same axis scales.
(D) CD8 SP thymocytes from B6 and BALB/cmouse were stained for Eomesodermin (Eomes) and pSTAT6. Numbers indicate frequency of cells in each quadrant
and the two plots have the same axis scales. Representative results of five independent experiments are shown. See also Figure S2.LN (iLN) or liver (Figures S4D and 4E). pSTAT6 expression in B
cells was not different between B6 and BALB/c mice (data not
shown), consistent with our observations that BALB/c NKT2
cells were preferentially localized in the T cell zone. This result
suggests that in the mLN, like in the thymus, NKT2 cells produce
IL-4 to influence neighboring T cells, as evidenced by pSTAT6
expression at steady state.
Splenic NKT1 Cells Are Mainly Localized in Red Pulp,
while NKT2 Cells Are in T Cell Zone
In spleen, we performed CD1d tetramer immunofluorescence
with various anatomical markers in serially sectioned tissues.
As shown in Figure 5A, section 2was stainedwith CD1d tetramer
and sections 1 and 3 were stained with TCRb, B220, type IV
collagen, CD169, and CD209b. These markers aid in defining T
and B cell zones, the marginal zone (CD169 and CD209b), and
splenic red pulp (type IV collagen). We differentiated NKT1 and
NKT2 cells using Tbx21gfp reporter mice and co-staining forImPLZF (Figure 5B). We found that NKT1 cells localized preferen-
tially in the red pulp, whereas NKT2 cells were in the T cell
zone of the white pulp (Figure 5C). We also performed i.v. anti-
body labeling of lymphocytes, which defines cells in blood,
splenic red pulp, and marginal zone (Anderson et al., 2014).
Consistent with the imaging analysis, we observed that NKT1
cells were more frequently i.v.+ than NKT2 cells (Figure 5D).
There was some inter-strain variation, in that a higher frequency
of B6 NKT1 cells were i.v.+ or defined as ‘‘vascular associated’’
compared to BALB/c mice, which was not seen in B cells or CD4
T cells (Figure S5). Collectively, these results show NKT1 and
NKT2 cells have distinct anatomic localization within spleen.
Vascular Localized NKT1 Cells Respond Rapidly to
aGalCer Challenge
Next, we asked how these differences in tissue and anatomic
localization of iNKT subsets influence activation upon aGalCer
challenge. Since the subsets produce distinct cytokines (NKT17munity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc. 569
Figure 3. iNKT Subsets Have Unique Periph-
eral Distribution, with Some Interstrain Vari-
ation
Frequencies of total iNKT cells among total CD45+
cells (A), mean frequencies of iNKT subsets among
total iNKT cells (B), and frequency of iNKT subsets
among total CD45+ cells (C) are shown in indicated
organs and strains of mice. i.v., intravenous
antibody unlabeled; i.v.+, intravenous antibody
labeled; Mes, Mesenteric; Axi, Axillary; Ing,
Inguinal; Cer, Cervical; Pan, Pancreas; IEL, Intra-
Epithelial Lymphocytes; PP, Peyer’s Patches; LPL,
Lamina Propria Lymphocytes. Each symbol rep-
resents an individual mouse (n = 49) and hori-
zontal bars indicate mean values. Pooled data from
eight independent experiments are shown. See
also Figure S3.produce IL-17, NKT2 produce IL-4, andNKT1 produce IFN-g and
some IL-4 depending on stimulation conditions), and CD69
expression is non-specifically upregulated on many lymphocyte
populations after aGalCer, we chose to measure the activation
of iNKT cells using the Nur77gfp reporter mouse, in which GFP
expression is rapidly and highly upregulated on iNKT cells when
stimulated via TCR engagement (Figure S6A) (Holzapfel et al.,
2014; Moran et al., 2011). When we compared GFP expression
in various organs 3 hr after i.v. aGalCer injection, iNKT cells in
thymus had not upregulatedGFP, as described in previous report
(Pellicci et al., 2003). Surprisingly, iNKT cells in the LN did not
respond at all, whereas most of hepatic iNKT cells and a majority
of splenic iNKT cells responded (Figure 6A). LN iNKT cells did not
showanyGFPupregulation at timepoints up to 6 hr after injection
(data not shown) suggesting that they did not become activated
through the TCR after lipid injection. In the spleen, a higher per-
centage of NKT1 cells expressed Nur77gfp after aGalCer chal-
lenge than NKT2 cells (Figure 6B). This difference did not reflect
a cell-intrinsic feature, becauseNKT2 cells efficiently upregulated
Nur77gfp expression after ex vivo activation (FigureS6B). Interest-
ingly, the percent of iNKT cells activated in each tissue was570 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.roughly correlated to the frequency of cells
labeled by i.v. antibody staining in that tis-
sues (Figure 6C) and thuswehypothesized
that only vascular-associated iNKT cells
responded immediately after i.v. aGalCer
challenge. To test this hypothesis, we
compared the endogenous response of
iNKT cells in red pulp (i.v.+) or white pulp
(i.v.) and found that both NKT1 and
NKT2 cells in the red pulp responded
quickly after aGalCer injection, whereas
cells in white pulp showed delayed activa-
tion (Figure 6D and Figure S6C). Further-
more, we adoptively transferred enriched
iNKT cells into aGalCer preinjected mice
as outlined in Figure 6E and harvested
the spleens of hostmice after 3 hr.We per-
formed CD1d tetramer based magnetic
bead enrichment to detect rare donor cells
(Figure S6D) and found that both LN iNKTcells andsplenicNKT2cells respondedwellwhen theywere local-
ized in thesplenic redpulp, confirming that localization rather than
a type of cells, determines the response to i.v. injected lipid (Fig-
ure 6F). As serum concentrations of IL-4 after aGalCer injection
peaked at 1.5 hr (Sullivan et al., 2010), these results suggest
that iNKT cells in the white pulp are not major contributors to
the serum cytokine response.
mLN NKT2 Cells Respond to Oral Administration of
aGalCer
Various routes of aGalCer delivery have been shown to differen-
tially affect immune responses (Furlan et al., 2003; Miyamoto
et al., 2001). Because i.v. injection of aGalCer did not activate
LN resident iNKT cells, we tested whether they could be acti-
vated by oral gavage of aGalCer. In contrast to i.v. injection,
oral administration of aGalCer specifically upregulated Nur77gfp
in mLN NKT cells and to a much lesser extent iNKT cells in liver,
but not in the spleen or thymus (Figures 7A and 7B). When we
compared iNKT subsets, only NKT2 cells upregulated Nur77gfp
(Figures 7C and 7D) and, consistent with this finding, IL-4 was
produced from these NKT2 cells (Figure S7A). NKT1 cells did
Figure 4. NKT2 Cells in BALB/c mLN Produce IL-4 and Condition Lymphocytes at Steady State
(A) Dot plots show total lymphocytes (left) or iNKT cells (right) from mesenteric lymph nodes (mLNs) of B6 (top) and BALB/c (botton) mice. Numbers indicated
frequency of cells in adjacent gates and all plots have the same axis scales. Representative data from at least five independent experiments are shown.
(B) Statistical analysis of frequencies of each iNKT subset among total lymphocytes in mLN of B6 (n = 9), BALB/c (n = 9) and NOD (n = 7) mice are shown.
*p = 0.0014, **p < 0.0001 (one-way ANOVA). NS, not significant. Horizontal bars indicate mean values.
(C) mLN of BALB/c Tbx21gfp mice was stained with indicated antibodies and CD1d tetramer. Arrows indicate NKT1 cells (green) and NKT2 cells (red).
(D) Average frequencies of each NKT subset among total iNKT cells in T and B cell zones were analyzed in B6 (n = 3) and BALB/c (n = 3) mice. Error bars
indicate SD.
(E) Human CD2 (huCD2) positive iNKT cells among total lymphocytes in mLN were analyzed in B6 (n = 6) and BALB/c (n = 6) mice. *p = 0.0009 (unpaired t test).
Each dot represents an individual mouse and horizontal bars indicate mean values.
(F) Flow cytometry plots show pSTAT6 expression of CD4 T cells in mLN. Numbers indicated percentage of cells in adjacent gates and the two plots have the
same axis scales.
(G) Statistical analysis of pSTAT6 expressing CD4 T cells in B6 and BALB/c mice (wild-type (WT), CD1d/ and il4ra/) (n = 3–4) is shown. *p = 0.001 (unpaired t
test). NS, not significant. Each dot represents an individual mouse and horizontal bars indicate mean values. See also Figure S4.not produce IFN-g or IL-4 upon oral administration of aGalCer,
although they produce both after i.v. injection (Figure S7A). Intra-
venous injection of aGalCer rapidly activated iNKT cells in spleen
and liver, and serum increases of both IFN-g and IL-4 could beImdetected as previously described (Figure S7B) (Sullivan et al.,
2010). The systemic release of IL-4 had effects at distant sites,
as evidenced by the observation that T cells in LNs upregulated
pSTAT6 (Figures 7E and 7F) even though LN NKT cells were notmunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc. 571
Figure 5. Splenic NKT1 Cells Are Mainly Localized in Red Pulp, while NKT2 Cells Are in T Cell Zone
(A) Five mm serial sections of spleen of BALB/c Tbx21gfp mice were stained with indicated combinations of antibodies and CD1d tetramer. A merged image in far
right shows combined boundaries of image #1 and image #3with green and red dots representing NKT1 and NKT2 cells from image #2. Representative images of
four independent experiments are shown.
(B) Representative images of NKT2 cells in T cell zone (top) and NKT1 cells in red pulp (red) are shown.
(C) Bar graphs show average frequencies of iNKT subsets in each anatomic region among total iNKT cells in B6 (n = 4) and BALB/c (n = 7) mice. Error bars
show SD.
(D) Frequencies of splenic NKT1 and NKT2 cells labeled with i.v. anti-CD45 staining are shown in B6 (n = 8) and BALB/c (n = 7) mice. *p < 0.0001, **p = 0.015
(unpaired t test). Each dot represents an individual mouse and horizontal bars indicate mean values. See also Figure S5.activated by i.v. injection of aGalCer (Figure 6A). However, after
oral gavage, there was no serum surge of IL-4 (Figure S7B)
and pSTAT6 upregulation was detected only in mLN and some-
what in liver, but not in spleen or iLN (Figures 7E and 7F). These
results indicate that oral gavage of lipid antigens can be used to
modulate the regional cytokine milieu in mLN without systemic
effects.
DISCUSSION
In this report, we provided an in-depth analysis of the tissue dis-
tribution and anatomic localization of iNKT cells. For detailed
analysis, we developed a CD1d tetramer-based histocytometry
approach, which provided an unbiased tool for analysis of immu-
nofluorescence data. As a result, we showed that IL-4 producing
NKT2 cells are enriched in the thymic medulla and the T cell zone
of mLNs. In both of these locations, they appear to condition
neighboring thymocytes and lymphocytes, as evidenced by
the expression of pSTAT6 at steady state. We also showed
that different routes of antigen delivery could activate iNKT cells
in different anatomic locations. Intravenous injection of aGalCer
activated NKT1 cells in spleen and liver with systemic IFN-g and572 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.IL-4 release, whereas oral gavage of aGalCer stimulated NKT2
cells in mLN with only local IL-4 effects only. Collectively these
results show that subset localization of iNKT cells is crucial to
determine which cytokines are produced and whether a sys-
temic or regional cytokine response ensues.
In the thymus, T-bet, GATA-3, and RORgt regulate lineage dif-
ferentiation of iNKT cells from a common progenitor (Constanti-
nides and Bendelac, 2013; Lee et al., 2013). Previously, we
showed that NKT2 cells secrete IL-4 at steady state in BALB/c
mice, which conditioned SP thymocytes to express Eomes,
stimulated thymic dendritic cell to secrete CCL17 and CCL22
and caused B cells to produce immunoglobulin E (Lee et al.,
2013). In this paper, we showed that NKT2 cells, and in particular
IL-4-producing NKT2 cells, mainly reside in the thymic medulla
and their IL-4 effect was confined to medullary thymocytes.
The medulla is a crucial environment for the development of
iNKT cells, because their numbers were sharply reduced in
relb/ thymi, which lack medullary epithelial cells (White et al.,
2014). As NK1.1+ iNKT cells were most strongly affected, we
infer that NKT1 cells in particular depend on medullary epithelial
cells for their development, which is to be expected since such
cells produce IL-15, a factor previously shown to be required
Figure 6. Vascular Localized NKT1 Cells Respond Rapidly to aGalCer Challenge
(A) BALB/c Nur77gfp mouse was i.v. injected with aGalCer and indicated organs were collected 3 hr later. Overlaid histograms show Nur77gfp expression in total
iNKT cells from aGalCer i.v. injected and uninjected control (CTL) mice. Representative histograms of at least five independent experiments are shown. All
histograms have the same axis scales. mLN, mesenteric lymph node; iLN, inguinal lymph node.
(B) Overlaid histogram showsNur77gfp expression in NKT1 (green) and NKT2 (red) cells 3 hr after aGalCer i.v. injection in BALB/c mice. Representative histogram
of at least five independent experiments is shown.
(C) Percentages of iNKT cells labeled with i.v. anti-CD45 antibody in corresponding organs of B6 (n = 3 8) and BALB/c (n = 37) mice are shown. Each dot
represents an individual mouse and horizontal bars indicate mean values.
(D) BALB/c Nur77gfp mice were i.v. injected with aGalCer and labeled with i.v. ant-CD45 antibody after indicated time periods. Three minutes later, mice were
sacrificed and analyzed forNur77gfp expressions. All histograms have the same axis scales. Representative results of three independent experiments are shown.
RP, red pulp; WP, white pulp.
(E) Schematic representation shows experimental procedure for (F). Va14TgNur77gfp (left) or CD45.1+ congenic B6 (right) mice were i.v. injected with aGalCer and
the latters were transferredwith LN cells of Va14TgNur77gfp mice. Three hr later, mice were sacrificed after CD45.1+ congenic B6 recipient mice were labeledwith
i.v. anti-CD45 antibody for 3 min.
(F) Histograms show Nur77 expression of NKT1 and NKT2 cells of spleen and LN of Va14Tg Nur77gfp mice (red) and donor iNKT cells in splenic red pulp of host
mice immunized (blue). Filled histogram shows Nur77 expression of NKT1 and NKT2 cells in unimmunized Va14Tg Nur77gfp mice. All histograms have the same
axis scales. Representative data of three mice are shown. See also Figure S6.
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Figure 7. mLN NKT2 Cells Respond to Oral Administration of aGalCer
(A) BALB/cNur77gfp mice were oral gavaged (OG) with 2 mg of aGalCer andNur77gfp expressions in total iNKT cells were analyzed after 24 hr. All histograms have
the same axis scales. Representative histograms of at least five independent experiments are shown. mLN, mesenteric lymph node; iLN, inguinal lymph node.
(B) Statistical analyses show frequencies of iNKT cells expressingNur77gfp in spleen, liver, and mLN of unimmunized control (CTL), i.v. aGalCer injected, and oral
gavaged (OG) BALB/c mice (n = 39). *p < 0.0001, **p = 0.0002 (one-way ANOVA). NS, not significant. Each dot represents an individual mouse and horizontal
bars indicate mean values.
(C and D) Overlay histograms show Nur77gfp expressions in NKT1 (green) and NKT2 (red) cells in BALB/c mice 24 hr after aGalCer oral gavage. Representative
histograms of three independent experiments (C) and its statistical analysis (n = 6) (D) are shown. All histograms have the same axis scales. **p = 0.001 (unpaired t
test). NS, not significant. Each dot represents an individual mouse and horizontal bars indicate mean values. MFI, mean florescence intensity.
(E) Histograms show pSTAT6 expression in CD4 T cells 3 hr after i.v. injection (top) or 24 hr after oral gavage (OG, bottom) of aGalCer. All histograms have the
same axis scales.
(F) Bar graphs show average percent point increases of pSTAT6 expression in CD4 T cells after i.v. injection or OG of aGalCer in BALB/c mice (n = 36). *p <
0.0001, **p = 0.0014, ***p = 0.0033 (unpaired t test). NS, not significant. Error bars show SD. See also Figure S7.for T-bet upregulation in iNKT cells (Castillo et al., 2010; Gordy
et al., 2011; White et al., 2014). Interestingly, iNKT cells also
promote the maturation of medullary epithelial cells, through
production of RANKL (White et al., 2014). Since NK1.1+ cells
(NKT1) do not produce RANKL, it is possible that NKT2 or
NKT17 cells provide this function. Our data would suggest that
both NKT2 and NKT17 cells are localized in the appropriate envi-
ronment for this.574 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.Regardless of subset or strain, an estimated 30% of NKT cells
were localized in the thymic cortex, in contrast to Treg cells, of
which only 1.5% were localized in the cortex. Because genetic
evidence has shown that iNKT cells are positively selected
from cortical DP thymocytes expressing RORgt (Egawa et al.,
2005), two possibilities can explain these observations: iNKT
cells might differentiate in the cortex and then migrate into the
medulla, or they might first migrate into the medulla, differentiate
into various subsets, and a fraction of them might move back to
the cortex. In the former scenario, younger mice would have a
higher frequency and older mice would have a lower frequency
of cortical iNKT cells. However, this was not the case when we
analyzed cortical localization of iNKT cells from 3- or 15-week-
old mice (data not shown). The latter scenario seemsmore likely,
considering that the medulla is required for differentiation to the
T-bet+ NKT1 subset (White et al., 2014), and that CCR7 a chemo-
kine receptor known to be involved in medullary localization is
expressed on ‘‘uncommitted’’ PLZFhi iNKT cells, but not on
differentiated NKT1, NKT2, or NKT17 cells (data not shown).
Other chemokine receptors might regulate localization as well.
For example, CXCR3 is expressed exclusively on NKT1 cells,
and its ligand CXCL10 produced by medullary thymic epithelial
cells was suggested to direct iNKT cell medullary localization
and long-term residency (Berzins et al., 2006; Drennan et al.,
2009). However, our analysis showed that not only NKT1 cells
but also NKT2 and NKT17 cells preferentially resided in the me-
dulla, indicating that CXCR3 is not the only factor regulating
medullary localization of iNKT cells. Further studies are required
to identify factors regulating cortico-medullary or medullo-cor-
tical migration of iNKT cells and to determine whether cortical
iNKT cells serve a particular function.
We extended our analysis of subset localization into other
lymphoid organs. The mLN of BALB/c mice were particularly en-
riched with NKT2 cells, especially in the T cell zone. These cells
also had an increased mean fluorescence intensity of Nur77gfp
in the steady state, suggesting that their antigen receptors were
being stimulated, and they produced IL-4 at steady state, which
conditioned surrounding T cells to phosphorylate STAT6. One
possible explanation of these observations is that microbial anti-
gens from the gut are carried to the mLN where they stimulate
NKT2 cells. A previous report showed that stimulation of intestinal
iNKT cells during the neonatal period by a sphingolipid from Bac-
teroides fragilis suppressed subsequent accumulation and path-
ogenic activation of iNKT cells in the colon and lung (An et al.,
2014; Olszak et al., 2012). In addition, iNKT cells from germ-free
mice showed reduced expression of CD5 and CD69 at steady
state and general hypo-responsiveness upon aGalCer challenge.
B6mice from Taconic, compared to those from Jackson Labora-
tory, have an increased frequency of iNKT cells in spleen and gut
that express TCR Vb7 and CD127, and the difference disappears
with co-housing (Wingender et al., 2012). Collectively, these re-
sults suggest that intestinal antigens provide homeostatic signals
to iNKT cells. However, it remains to be determined whether the
intestinal microbiome regulates inter-strain differences in iNKT
cell development and/or activation in the mLN.
Recently, two more subsets of iNKT cells have been des-
cribed; NKTFH (follicular helper NKT) and NKT10 cells expressing
transcription factor Bcl6 and E4BP4 respectively (Chang et al.,
2012; Lynch et al., 2015; Sag et al., 2014). NKTFH cells are local-
ized in germinal center and provide help to B cells. NKT10 cells
are localized in white adipose tissue and secrete IL-10 to create
immunoregulatory environment. We did not analyze these cells
because they are not found in lymphoid organs at steady state
or induced at later time points after immunization.
Intravenous administration of aGalCer immediately activated
iNKT cells with vascular access, but not iNKT cells in LN or
thymus. It is not clear why these iNKT cells are not responsive,Imbut we showed that it was not an intrinsic feature of LN iNKT cells
(Figure 6F). It is possible that serum components such as lipid
binding proteins (van den Elzen et al., 2005) restrict aGalCer dis-
tribution to the vascular compartment or that antigen presenting
cells in the LN are not specialized to present lipid antigens.
Oral antigenic intake induces tolerogenic T cell responses
(Pabst and Mowat, 2012). However, co-administration of oral
aGalCer together with protein antigens induced a protective im-
mune response against tumor cells expressing the cognate anti-
gens (Silk et al., 2004). The adjuvant effects were not seen by i.v.
injection of aGalCer, suggesting that routes of antigenic delivery
are critical. In this paper, we provided mechanistic insight as to
how oral aGalCer exerts its effects; oral aGalCer specifically ac-
tivates NKT2 cells in mLN to produce IL-4.
After oral gavage, it took about 7 hr before iNKT cells began to
be activated in mLN and the response peaked at 24 hr (data not
shown). We think this delay might be due to the requirement of
antigen-presenting cells to traffic from intestine to mLN. In
mLN, NKT2 cells might share an anatomic niche with migrating
dendritic cells or migrating dendritic cells might be specialized
to activate only NKT2 cells, but not NKT1 cells via their expres-
sion patterns of co-stimulatory molecules or secreted factors.
However, this is not consistent with previous findings that
migrating dendritic cells in the mLN favor the differentiation of
Th1 and/or Th17 cells, but not Th2 cells (Cerovic et al., 2014).
Inflammatory bowel diseases such as Crohn’s disease and
ulcerative colitis are chronic relapsing inflammatory disorder in-
volving the gastrointestinal tract (Kaser et al., 2010). Immunolog-
ically, pathogenic Th1 and Th2 responses characterize these two
diseases, respectively. Our finding that oral aGalCer administra-
tion induced an IL-4 rich environment in the mLN has clinical im-
plications, because oral aGalCer might be able to suppress
pathogenic Th1 cell activation in Crohn’s disease, while it might
worsen Th2 driven ulcerative colitis. We also showed that oral
aGalCer induced an IL-4 effect confined to mLN, which could
minimize potential systemic side effects. Intravenous injection
of aGalCer eventually induces NKT10 cells secreting IL-10 long
after immunization in spleen (Sag et al., 2014) and if this is the
same case in mLN after oral gavage of aGalCer, it might be help-
ful to suppress both Th1 or Th2 driven inflammation as IL-10 is
critical for suppressing pathogenic T cell activation in the gut
(Saraiva and O’Garra, 2010).
The systemic distribution of iNKT cells in humans is different
from that of mice. In humans, iNKT cells are not enriched in liver,
and the small intestine is a major organ where iNKT cells are
localized early in life (Loh et al., 2014). In human clinical trials,
i.v. aGalCer injection failed to increase serum IL-4 or IFN-g in a
majority of subjects (Giaccone et al., 2002), which has been
attributed to their low numerical abundance, as humans have a
lower proportion of iNKT cells in blood than mice, albeit with
two-log phase variability between individuals (Lee et al., 2002).
However, our results suggest that not only numerical issues,
but also qualitative issues such as the localization and subset
differentiation are crucial for in vivo activation and cytokine
secretion from iNKT cells upon aGalCer challenge. Because
parabiosis experiments suggest that iNKT cells do not circulate
(Lynch et al., 2015; Thomas et al., 2011), i.v. injection of aGalCer
might not be an ideal therapeutic strategy if the majority of hu-
man iNKT cells are not readily accessible to the vasculature. Inmunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc. 575
this context, the type and localization of human iNKT cells and
the most efficient immunization routes to activate them must
be clarified.
EXPERIMENTAL PROCEDURES
Mice
B6 (C57BL/6NCr) mice were purchased from the National Cancer Institute.
BALB/c (BALB/cJ or BALB/cByJ), Cd1d/ BALB/cJ (C.129S2-Cd1tm1Gru/J),
Il4ra/ BALB/cJ (BALB/c-Il4ratm1Sz/J), and NOD (NOD/ShiLtJ) mice were
from Jackson Laboratory. B6 and BALB/c Tbx21gfp and Tbx21gfp KN2+/ mice
were described previously (Lee et al., 2013). Va14Tg Nur77gfp TCR transgenic
B6 mice were described before (Holzapfel et al., 2014). All the mouse experi-
ments were performed under protocols approved by the Institutional Animal
Care and Use Committee of the University of Minnesota.
Immunofluorescence
For CD1d tetramer immunofluorescence, fresh thymic lobes, whole lymph no-
des, or 1–2 mm thickness spleen trans-sections were overnight incubated in
50 ml phosphate buffered saline (PBS) solution containing 1:101:25 dilution
of R-Phycoerythrin (PE) labeled PBS-57 loaded CD1d tetramer in 2% fetal
calf serum containing PBS at 4C. Next day, tissues were washed three times
with PBS, fixed with 4% paraformaldehyde (PFA) for 1 hr and snap frozen. Five
micrometer tissue sections were blocked with 5% bovine serum albumin and
goat sera (Jackson Laboratory) for 1 hr at 25C and stained with anti-PE anti-
body (Novus Biologicals, rabbit polyclonal) followed by goat anti-rabbit AF555
(Life Technology). For human CD2 immunofluorescence, tyramide-based
amplification was done according to manufacturer’s instruction (PerkinElmer)
after staining with anti-human CD2 (RPA2) antibody. RORgt (RORg2, Millipore
or Q31-378, BD) and PLZF (D9, SantaCruz or R17-809, BD) were stained fol-
lowed by goat anti-hamster IgG (Jackson Laboratory) and goat anti-mouse
IgG1 (Southern Biotech).
Histocytometry
Histocytometric analysiswasperformedasdescribedpreviously, withmodifica-
tions (Gerner et al., 2012). Briefly, fluorochrome intensities of each single region
of interest were quantified using ImageJ and data were exported into Excel and
Prism software for two-dimensional plotting. XY coordinates of gated popula-
tions were overlaid on original images to analyze localization. For comparison
between histocytometry and flow cytometry in thymus, we obtained 30 to 50
thymic stitch images containing a total of 5 3 104 105 cells and adjusted the
medullary fraction to 20% as previously described (Irla et al., 2013).
Flow Cytometry
Single-cell suspensions were prepared from thymi, spleens, and lymph nodes,
and hepatic mononuclear cells were separated by Percoll gradient. Bio-
tinylated PBS-57 loaded or unloaded CD1d monomers were obtained from
the tetramer facility of the US National Institutes of Health. For intracellular
staining, single cell suspensions were surface stained, fixed, and permeabi-
lized with eBioscience Foxp3 staining buffer set. For pSTAT6 staining, cells
were fixed with 1.6% PFA (25C) and methanol (20C) for 10 min, respec-
tively, and stained with surface and intracellular markers. For in vitro IL-4
culture, total thymocytes were incubated for 30 min in 10 ng/ml IL-4
(eBioscience). For isolation of lymphocytes from lung parenchyma, we labeled
circulating cells as described before (Anderson et al., 2014) and chopped
tissues were digested with collagenase D (Roche). All antibodies were from
eBioscience, BD or BioLegend, unless indicated. Cells were analyzed on an
LSR II (Becton Dickinson) and data were processed with FlowJo software
(TreeStar).
Enzyme-Linked Immunosorbent Assay
A mouse IL-4 and IFN-g ELISA MAX kit (BioLegend) was used for quantifica-
tion of serum cytokines.
In Vitro Stimulation of iNKT Cells
Splenocytes of Va14Tg Nur77gfp TCR transgenic mouse were resuspended in
RPMI media containing 10% FCS at 53 106 cells/ml concentrations. PE con-576 Immunity 43, 566–578, September 15, 2015 ª2015 Elsevier Inc.jugated PBS-57 loaded CD1d tetramer or PE conjugated empty CD1d
tetramer was added in media and cultured for 4 hr at 37C. GFP expression
was determined by flow cytometry analysis after in vitro stimulation.
Lipid Injection
Two micrograms of a-galactosylceramide (Avanti Polar Chemical, KRN7000)
were dissolved in DMSO (1mg/ml), diluted in PBS and intravenously injected
or oral gavaged. Control mice were administrated with DMSO/PBS. Mice
were analyzed after 3 or 24 hr, respectively, if not otherwise indicated.
Statistical Analysis
Prism software (Graphpad) was used for statistical analysis. ANOVA and t test
(paired or unpaired, two-tailed) were used for data analysis and the generation
of p values.
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